Hemoglobinopathies and Related Disorders Open access Peer reviewed

Global genetic modifiers of fetal hemoglobin in sickle cell disease: Systematic review and meta-analysis

Nandini Shende, Shreyasi Athalye, Samriddhi Kamath, Priya Rani and 3 more

iScience | Aug 17, 2026

Abstract

Abstract

Fetal hemoglobin (Hb F) is the strongest endogenous modifier of sickle cell disease (SCD) severity, but its genetic regulation varies across populations. This review synthesized evidence on genetic determinants of Hb F and quantified effects of key variants through meta-analysis. Following PRISMA 2020 guidelines (PROSPERO: CRD420251042025), MEDLINE, EMBASE, Scopus, and Web of Science were searched through May 2026. Studies evaluating genetic associations with Hb F levels in SCD were included. Narrative synthesis and random-effects meta-analysis were performed. Eighty-four studies identified 80 variants across 32 genes associated with Hb F levels. The most consistently replicated associations involved BCL11A (rs1427407, rs4671393, and rs11886868), the HBS1L-MYB intergenic region (rs4895441, rs28384513), HBG2 (rs7482144), and HMOX1 (rs2071746). Meta-analysis confirmed directionally consistent associations for seven of eight variants. Additional modifiers included SIN3A , ZBTB7A , ANTXR1 , FOXO3 , BACH2 , and HIF-1α . Hb F regulation in SCD is polygenic and influenced by both canonical and secondary modifiers, supporting genotype-guided therapeutic, and genome-editing strategies.

Direct answer

What can I do from this paper page?

Use this page to scan "Global genetic modifiers of fetal hemoglobin in sickle cell disease: Systematic review and meta-analysis" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Hemoglobinopathies and Related Disorders research, save the paper, or map adjacent work.

Authors

Researchers on this paper

Nandini Shende

first | ICMR - National Institute of Immunohaemotology

Shreyasi Athalye

middle | ICMR - National Institute of Immunohaemotology | ORCID 0000-0002-0014-0009

Samriddhi Kamath

middle | ICMR - National Institute of Immunohaemotology

Priya Rani

middle | Immunotherapy Centre for Prevention of Repeated Miscarriages

Manisha Madkaikar

middle | ICMR - National Institute of Immunohaemotology

Anindita Banerjee

middle | ICMR - National Institute of Immunohaemotology

Naveen Khargekar

last | ICMR - National Institute of Immunohaemotology

Research areas

Follow related topics

Citation

BibTeX

@article{Shende2026Global,
  title = {Global genetic modifiers of fetal hemoglobin in sickle cell disease: Systematic review and meta-analysis},
  author = {Nandini Shende and Shreyasi Athalye and Samriddhi Kamath and Priya Rani and Manisha Madkaikar and Anindita Banerjee and Naveen Khargekar},
  journal = {iScience},
  year = {2026},
  doi = {10.1016/j.isci.2026.116997},
  url = {https://doi.org/10.1016/j.isci.2026.116997}
}

FAQ

Using this paper in a discovery workflow

How do I find related work for this paper?

Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.

How can I keep up with new Hemoglobinopathies and Related Disorders research papers?

Follow Hemoglobinopathies and Related Disorders research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.

Can I cite this paper from this page?

This page includes a static BibTeX block for Global genetic modifiers of fetal hemoglobin in sickle cell disease: Systematic review and meta-analysis. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.

Follow this research in Scollr

Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.

Get the app